my biggest investment yet is £800 in Ovaco Gold, still trading at a discount to cash and investments, they've enough funding for three years and could have a mine going in 2013 http://www.proactiveinvestors.co.uk/...
One of my favourite tipsters says avoid Rockhopper mostly because their poor cashflow will mean dilution to small holders (these companies never give rights). On the other hand he backs Gulfsands because they have assets/production inc. USA plus exploration in MENA
Well I've just invested £500 into hambledon mining, topped up barc, put £250 into northumbrian water with a view to put another £250 in next week, also bought £300 regency mines and will top up later (same bloke who runs red rock resources runs this). proactive invester arcticle on hambledon mining here.
Thanks for the adviceDon't take this the wrong, just some helpful advice really, but when you take fees and what you could make into account, there is little good in putting small amounts, eg £250, into different companies. With the £1000 odd you have invested, you have already probably lost an amount in fees which could be as much as 5%.
I did the same when I was just starting out, but I very rarely trade less than £2k in one transaction now.
Best thing someone said to me was don't trade with more than you can afford to lose.
Mal![]()
Yeah I think I'll get the naked trader book at somepoint.^^ I'd really recommend the Naked Trader book. Was recommended to me from here and I'm 3/4 of the way through and it's been great.
From a £250 trade, a £12.50 commission fee (plus that again when you sell remember) is a huge percentage of your overall trade. Combined with the stamp duty and spread and you've instantly put yourself in a position whereby you need a fairly large % increase even just to break even.
To begin with I wouldn't have been comfortable putting in a lot of money as I didn't feel I really knew what I was doing and I'm still learning.
Reality is virtually no-one actually knows what they're doing (except for a few billionaires) everyone else is just kidding themselves.
Though as the previous poster pointed out transaction costs can hurt you a lot when it comes to small investments - you mentioned in your post something about investing £250 in a stock with a view to putting in another £250 next week? If its a long term investment then what are you waiting for to happen over the next week - on what basis would you invest/not invest the other £250... if you think the stock will perform well then why not just invest the full £500 now.
As for learning etc.. if you're investing over a period of a few years then there isn't much you can do in terms of practicing picking stocks. You can't paper trade for example, you'd run your mock portfolio a few times and by the time you feel you're ready to invest you'd be 80 odd and about to die soon. You could maybe use historical data but then again you're presumably using more than just price data for your decisions.
Personally I'd just take the plunge and run with it, read the books, don't just invest in these speculative small cap stocks and give yourself clear entry/exit strategies etc... not I'll stick a bit in xyz then maybe next week if I feel confident I'll stick a bit more in... You want to have a decent reason for investing and also plan your exit, if XYZ drops a certain % what will you do, at what point do you cut your losses(consider a stop loss), similarly how long are you going to let it run before you take profit - trailing stop perhaps. Similarly if it does naff all how long before you exit and invest in something else. You really want to plan this stuff in advance else you'll be left looking a XYZ going down, then browsing some internet forums where people are saying its still a good buy, then watching it drop a bit more etc..etc.. It all needs to be unemotional, don't listen to BS opinions about individual stocks on the internet, do your own research, set your targets, set your stop loss etc...
How, wait a month?There's better ways of avoiding peaks than splitting your buy into two separate trades a week apart. What if both those days have a peak by coincidence?
Bought the following on my virtual trading account (BB): BOY, BLND, DCC, LAND and MML. Also watching BOD and NAD closely.
How, wait a month?
I think interactive investor is owned by HBOS.£1.50 a trade sounds like Halifax sharebuilding account
Well it might have given more time for movement...Eh? How does that even make sense?
Look at its graph and work out its resistance and support levels would be the quickest way.
RNS Number : 6161E
GW Pharmaceuticals PLC
11 April 2011
GW Signs Exclusive Licence Agreement to Commercialise Sativex® in Australia, Asia, Middle-East and Africa
Porton Down, UK; 11 April 2011: GW Pharmaceuticals plc (AIM:GWP) today announces that it has entered into an exclusive licence agreement for Novartis Pharma AG to commercialise Sativex® in Australia and New Zealand, Asia (excluding Japan, China and Hong Kong), Middle East (excluding Israel/Palestine) and Africa.
Under the terms of the agreement, Novartis will have exclusive commercialisation rights to Sativex® and will also be responsible for regulatory filings and act as Marketing Authorisation holder for Sativex®. GW will be responsible for the manufacture and supply of Sativex® to Novartis.
Sativex® has been developed as a treatment for spasticity due to Multiple Sclerosis (MS). It is anticipated that regulatory filings for Sativex® in MS will begin in some of the countries in the above region during 2011. Sativex® is also in Phase III clinical development for the treatment of cancer pain.
Under the agreement, GW will receive an upfront payment of $5 million and will be eligible for additional payments totaling $28.75 million upon the achievement of certain approval and commercial milestones. In addition, GW will receive royalties on net sales of Sativex®.
Justin Gover, GW's Managing Director, said, "We are delighted to have entered into this agreement with Novartis. As one of the world's leading pharmaceutical companies with a strategic focus in both MS and oncology, Novartis represents an excellent commercial partner for Sativex in these important and growing international markets."
Sativex® is licensed to Otsuka Pharmaceutical Co. Ltd in the United States, to Almirall S.A. in Europe (excluding the United Kingdom), to Bayer HealthCare AG in the UK and Canada, and to Neopharm Group in Israel/Palestine.
MAX PETROLEUM PLC
("MAX PETROLEUM" OR THE "COMPANY")
[AIM: MXP]
11 April 2011
Successful Triassic Appraisal Well Drilled in the Zhana Makat Field
Max Petroleum Plc, an oil and gas exploration and development company focused on Kazakhstan, is pleased to announce today that the ZMA-ET1 appraisal well in the Zhana Makat Field has reached a total depth of 1,472 metres, with electric logs indicating 22 metres of net oil pay in three Triassic sandstone reservoirs at depths ranging between 1,282 and 1,410 metres. Reservoir quality appears excellent with porosities ranging from 18 to 26%. These reservoirs were the primary objective of this well, which appears to have successfully extended Triassic production and reserves into the southern end of the Field.
The Company is running production casing in the well, after which the Sun ZJ-30 drilling rig will move on to drill the ZMA-ET2 appraisal well further to the south of the ZMA-ET1 well, attempting to further extend Triassic production and reserves in Zhana Makat. The Company will complete and test the ZMA-ET1 well using a workover rig over the next several weeks and will announce production test results as soon as practicable.
What brokers do people use here for spread betting?